These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. Woods JA, Usery JB, Self TH, Finch CK. South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782 [Abstract] [Full Text] [Related]
3. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Goggin N, Macarthur C, Parkin PC. Arch Pediatr Adolesc Med; 2001 Dec; 155(12):1329-34. PubMed ID: 11732951 [Abstract] [Full Text] [Related]
4. Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomized trial. Nouira S, Bouida W, Grissa MH, Beltaief K, Trimech MN, Boubaker H, Marghli S, Letaief M, Boukef R. Am J Ther; 2014 Dec; 21(3):152-8. PubMed ID: 22407196 [Abstract] [Full Text] [Related]
5. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease. Kässner F, Hodder R, Bateman ED. Drugs; 2004 Dec; 64(15):1671-82. PubMed ID: 15257628 [Abstract] [Full Text] [Related]
6. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Craven D, Kercsmar CM, Myers TR, O'riordan MA, Golonka G, Moore S. J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512 [Abstract] [Full Text] [Related]
7. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. Qureshi F, Pestian J, Davis P, Zaritsky A. N Engl J Med; 1998 Oct 08; 339(15):1030-5. PubMed ID: 9761804 [Abstract] [Full Text] [Related]
8. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. Aaron SD. J Asthma; 2001 Oct 08; 38(7):521-30. PubMed ID: 11714074 [Abstract] [Full Text] [Related]
9. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L, Forget A, Ramachandran S. Clin Ther; 2010 Jul 08; 32(7):1320-8. PubMed ID: 20678680 [Abstract] [Full Text] [Related]
10. Principal findings of systematic reviews of acute asthma treatment in childhood. Castro-Rodriguez JA, J Rodrigo G, E Rodríguez-Martínez C. J Asthma; 2015 Jul 08; 52(10):1038-45. PubMed ID: 26303207 [Abstract] [Full Text] [Related]
11. The effect of indacaterol during an acute exacerbation of COPD. Segreti A, Fiori E, Calzetta L, Sabatini M, Segreti V, Rogliani P, Cazzola M. Pulm Pharmacol Ther; 2013 Dec 08; 26(6):630-4. PubMed ID: 23578980 [Abstract] [Full Text] [Related]
12. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD. Pauwels R, Joos GF, Fogarty C, Faiferman I, Hirschberg S, Vessey R, Wouters EF. Pulm Pharmacol Ther; 2008 Dec 08; 21(2):385-92. PubMed ID: 18023600 [Abstract] [Full Text] [Related]
13. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC, Combivent Respimat Inhaler Study Group. Respir Med; 2010 Aug 08; 104(8):1179-88. PubMed ID: 20172704 [Abstract] [Full Text] [Related]
14. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen. Shortall SP, Blum J, Oldenburg FA, Rodgerson L, Branscombe JM, Harrow EM. Respir Care; 2002 Feb 08; 47(2):154-8. PubMed ID: 11812271 [Abstract] [Full Text] [Related]
15. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma. Hossain AS, Barua UK, Roy GC, Sutradhar SR, Rahman I, Rahman G. Mymensingh Med J; 2013 Apr 08; 22(2):345-52. PubMed ID: 23715360 [Abstract] [Full Text] [Related]
16. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma. Memon BN, Parkash A, Ahmed Khan KM, Gowa MA, Bai C. J Pak Med Assoc; 2016 Mar 08; 66(3):243-6. PubMed ID: 26968269 [Abstract] [Full Text] [Related]
17. Metered-dose inhaler ipratropium bromide for children with acute asthma exacerbation: A prospective, non-randomized, observational study. Nomura O, Ihara T, Morikawa Y, Sakakibara H, Hagiwara Y, Inoue N, Akasawa A. Pediatr Int; 2020 Mar 08; 62(3):319-323. PubMed ID: 31930755 [Abstract] [Full Text] [Related]
18. Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office. Kumaratne M, Gunawardane G. Clin Pediatr (Phila); 2003 Mar 08; 42(2):127-32. PubMed ID: 12659385 [Abstract] [Full Text] [Related]
19. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? Akkoca Yildiz O, Onen ZP, Demir G, Eriş Gülbay B, Saryal S, Karabiyikoğlu G. Tuberk Toraks; 2006 Mar 08; 54(2):105-13. PubMed ID: 16924565 [Abstract] [Full Text] [Related]
20. Anticholinergic agents in asthma and COPD. Gross NJ. Eur J Pharmacol; 2006 Mar 08; 533(1-3):36-9. PubMed ID: 16488410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]